Unveiling the role of oncogenic K-ras in the development of human cancer has been greatly aided by the ability to manipulate the mouse genome in order to develop tumour models of sporadic K-ras activation, which closely recapitulate those events responsible for human disease 7–14. The gene discussed is KRAS; the disease is cancer.